Cytokine-dependent long-term culture of highly enriched precursors of hematopoietic progenitor cells from human bone marrow

J Brandt, E F Srour, K van Besien, R A Briddell, R Hoffman, J Brandt, E F Srour, K van Besien, R A Briddell, R Hoffman

Abstract

Human marrow cells positive for the CD34 antigen but not expressing HLA-DR, CD15, or CD71 antigens were isolated. In a liquid culture system supplemented with 48-hourly additions of recombinant interleukins IL-1 alpha, IL-3, IL-6, or granulocyte/macrophage colony-stimulating factor (GM-CSF), these cells were capable of sustaining in vitro hematopoiesis for up to eight weeks. The establishment of an adherent cell layer was never observed. Cultures containing no exogenous cytokine produced clonogenic cells for only 1 wk. IL-1 alpha and IL-6 were alone able to support hematopoiesis for 2 or 3 wk. Cells maintained with GM-CSF proliferated and contained assayable colony-forming cells for 3 or 4 wk, while maximal cellular expansion and generation of assayable progenitor cells occurred in the presence of IL-3 for 4-5 wk. When IL-3 was combined with IL-1 alpha or IL-6, hematopoiesis was sustained for 8 wks. Basophil numbers were markedly increased in the presence of IL-3. These studies indicate that marrow subpopulations can sustain hematopoiesis in vitro in the presence of repeated additions of cytokines. We conclude that a major function of marrow adherent cells in long-term cultures is that of providing cytokines which promote the proliferation and differentiation of primitive hematopoietic cells.

References

    1. Exp Hematol. 1988 Jun;16(5):371-7
    1. J Clin Invest. 1987 Jun;79(6):1549-57
    1. J Cell Physiol. 1986 Jun;127(3):403-9
    1. Cell. 1986 Jun 6;45(5):667-74
    1. J Immunol. 1987 Sep 15;139(6):1823-9
    1. J Clin Invest. 1988 Sep;82(3):1017-27
    1. Mol Cell Biol. 1989 Jun;9(6):2748-51
    1. Blood. 1987 Mar;69(3):953-6
    1. Blood. 1987 Mar;69(3):804-8
    1. J Cell Physiol. 1987 Jan;130(1):150-6
    1. Blood. 1986 Nov;68(5):1030-5
    1. Exp Hematol. 1986 Oct;14(9):878-86
    1. Lymphokine Res. 1986 Winter;5(1):59-72
    1. Blood. 1979 May;53(5):1023-7
    1. J Exp Med. 1989 May 1;169(5):1721-31
    1. Blood. 1989 May 15;73(7):1763-9
    1. Blood. 1989 Aug 1;74(2):613-21
    1. Blood. 1989 Aug 1;74(2):609-12
    1. Blood. 1989 May 15;73(7):1836-41
    1. Science. 1988 Jul 1;241(4861):58-62
    1. Exp Hematol. 1988 May;16(4):307-12
    1. Blood. 1988 Dec;72(6):2007-14
    1. Blood. 1988 Jun;71(6):1759-63
    1. J Cell Physiol. 1988 Feb;134(2):292-6
    1. J Immunol. 1988 May 1;140(9):3040-4
    1. Blood. 1988 Feb;71(2):329-34
    1. Blood. 1984 Dec;64(6):1159-62
    1. Blood. 1987 Apr;69(4):1120-7
    1. Blood. 1986 May;67(5):1418-26
    1. Proc Natl Acad Sci U S A. 1987 Dec;84(24):9035-9
    1. J Cell Physiol. 1987 Aug;132(2):203-14
    1. Proc Natl Acad Sci U S A. 1987 Oct;84(20):7134-8
    1. J Cell Physiol. 1986 Oct;129(1):20-6
    1. Blood. 1987 Apr;69(4):1021-5
    1. Blood. 1986 Mar;67(3):842-5
    1. J Cell Physiol. 1985 Aug;124(2):182-90
    1. Nature. 1985 Aug 15-21;316(6029):633-6
    1. Exp Hematol. 1985 Oct;13(9):937-40
    1. Cytometry. 1983 Mar;3(5):323-7
    1. Blood. 1983 Aug;62(2):291-7
    1. Int J Cell Cloning. 1983 Apr;1(1):49-56
    1. Blood. 1982 Sep;60(3):703-13
    1. J Exp Med. 1984 Jun 1;159(6):1576-90
    1. Exp Hematol. 1984 Jun;12(5):327-38
    1. Blood. 1984 Aug;64(2):516-25
    1. J Cell Physiol. 1984 Jan;118(1):45-52
    1. Blood. 1983 Jun;61(6):1222-31
    1. Blood. 1980 Nov;56(5):798-805
    1. Proc Natl Acad Sci U S A. 1981 Jun;78(6):3629-33
    1. Proc Natl Acad Sci U S A. 1980 Aug;77(8):4756-9
    1. J Clin Invest. 1982 Dec;70(6):1324-8
    1. J Clin Invest. 1981 Sep;68(3):733-41
    1. Blood. 1981 Aug;58(2):309-16
    1. Blood. 1980 Jul;56(1):118-24
    1. J Cell Physiol. 1977 Jun;91(3):335-44
    1. Blood Cells. 1979 Jun 15;5(2):297-311

Source: PubMed

3
订阅